Portfolio Lab

BioLineRx Ltd.

  • Stock
  • Ticker BLRX
  • ISIN US09071M3043
  • NASDAQ
  • US listing in dollars (ADR)

Performance, volatility and drawdowns of BioLineRx Ltd. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

1-year return
−71.5%
5-year return p.a.
−61.0%
10-year return p.a.
−47.8%
Volatility p.a.
69.0%
Largest decline
−99.9%

Performance

BLRXGlobal equities (VT)

$10,000 grew to $15. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −99.9% in 11/2026, measured from the peak in 10/2018. The old peak has not been reached again yet.

Annual returns

Best year 2023 at +166.1%, weakest 2024 at −86.4%. 3 of 9 full years were positive. * partial year.

Compared with Global equities

Since 11/2016BLRXGlobal equities (VT)
Return p.a.−47.8%+11.3%
Volatility p.a.69.0%15.1%
Largest decline−99.9%−34.2%
Return per unit of risk-0.690.74
$10,000 grew to$15$29,042

Bold: the better value in each row. Return per unit of risk: return p.a. divided by volatility p.a. Correlation of monthly returns with Global equities: 0.45 (1 would mean they moved in lockstep).

More stocks of similar size

Test BLRX in your own portfolio

Mix it with other securities, set recurring investments and costs, compare against a broad equity ETF. No account needed.

Open in backtest

Frequently asked questions

How has BLRX performed since 11/2016?

$10,000 grew to $15 by 20 Nov 2026, which is −47.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BLRX?

Volatility was 69.0% per year, measured on monthly returns. The largest decline from a peak was −99.9%, with the low in 11/2026.

How does BLRX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BLRX returned −47.8% at 69.0%. The correlation of monthly returns was 0.45; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's depositary receipt (ADR) traded in the US. On individual days its path differs slightly from the price on the home exchange.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.